Regeneron (REGN) ebitda was $5.1B in FY2025 (-6% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$5.1B
-6%
2024
$5.5B
+2%
2023
$5.4B
-8%
2022
$5.8B
-41%
2021
$9.8B
+132%
2020
$4.2B
+47%
2019
$2.9B
-7%
2018
$3.1B
+14%
2017
$2.7B
+37%
2016
$2.0B
+12%
2015
$1.8B
+49%
2014
$1.2B
+20%
2013
$1000M
+70%
2012
$589M
+599%
2011
-$118M
-211%
2010
-$38M
-32%
2009
-$29M
+33%
2008
-$42M
Recent Quarterly EBITDA
Quarter
EBITDA
Q1 2026
$1.0B
Q4 2025
$1.3B
Q3 2025
$1.4B
Q2 2025
$1.5B
Q1 2025
$974M
Q4 2024
$1.4B
Q3 2024
$1.5B
Q2 2024
$1.4B
Q1 2024
$1.1B
Q4 2023
$1.3B
Q3 2023
$1.4B
Q2 2023
$1.3B
Source: REGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.